Table: Chugai Pharm -2021 group results (IFRS)

Chugai Pharmaceutical

03/02/2022 08:00

Feb 3 (Reuters)- 
              Chugai Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to        NEXT  
                Dec 31, 2021    Dec 31, 2020   Dec 31, 2022      YEAR    
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULT        FORECAST    H1 FORECAST 
  Sales            999.76          786.95                                
                 (+27.0 pct)     (+14.7 pct)                             
  Operating        421.90          301.23                                
                 (+40.1 pct)     (+43.0 pct)                             
  Pretax
  Net              303.00          214.73                                
                 (+41.1 pct)     (+36.3 pct)                             
  EPS Basic      184.29 yen      130.66 yen                              
  EPS Diluted    184.17 yen      130.53 yen                              
  Ann Div         76.00 yen                      76.00 yen               
  -Q2 Div         30.00 yen       75.00 yen      38.00 yen               
  -Q4 Div         46.00 yen       30.00 yen      38.00 yen               
 
  NOTE - Chugai Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4519.T